We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$4.44B
AUM Growth
+$369M
Cap. Flow
+$154M
Cap. Flow %
3.48%
Top 10 Hldgs %
37.84%
Holding
1,573
New
168
Increased
590
Reduced
551
Closed
38

Sector Composition

Rank Sector Weight
1 Technology 7.03%
2 Financials 4.53%
3 Healthcare 3.19%
4 Industrials 2.87%
5 Communication Services 2.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SABR icon
1326
Sabre
SABR
$656M
$1.1K ﹤0.01%
+602
New +$1.42K
ARES.PRB
1327
Ares Management Corp 6.75% Series B Preferred Stock
ARES.PRB
$1.22B
$1.09K ﹤0.01%
22
RHI icon
1328
Robert Half
RHI
$3.61B
$1.09K ﹤0.01%
32
-36
-53% -$1.35K
SPR
1329
DELISTED
Spirit AeroSystems
SPR
$1.08K ﹤0.01%
28
DHT icon
1330
DHT Holdings
DHT
$2.97B
$1.08K ﹤0.01%
90
+35
+64% +$406
EWBC icon
1331
East-West Bancorp
EWBC
$17.9B
$1.06K ﹤0.01%
10
USFR icon
1332
WisdomTree Floating Rate Treasury Fund
USFR
$18.1B
$1.06K ﹤0.01%
21
-208
-91% -$10.5K
FYBR
1333
DELISTED
Frontier Communications
FYBR
$1.05K ﹤0.01%
28
DNLI icon
1334
Denali Therapeutics
DNLI
$3.67B
$1.03K ﹤0.01%
+71
New +$1.02K
FPI
1335
Farmland Partners
FPI
$419M
$1.02K ﹤0.01%
94
-31
-25% -$340
CHWY icon
1336
Chewy
CHWY
$8.54B
$1.01K ﹤0.01%
+25
New +$964
SNN icon
1337
Smith & Nephew
SNN
$12.9B
$980 ﹤0.01%
27
VKTX icon
1338
Viking Therapeutics
VKTX
$4.04B
$972 ﹤0.01%
37
-37
-50% -$1.1K
TWST icon
1339
Twist Bioscience
TWST
$5.62B
$957 ﹤0.01%
+34
New +$1.03K
FC icon
1340
Franklin Covey
FC
$233M
$951 ﹤0.01%
+49
New +$970
HAYW icon
1341
Hayward Holdings
HAYW
$3.13B
$937 ﹤0.01%
+62
New +$950
USLM icon
1342
United States Lime & Minerals
USLM
$3.18B
$921 ﹤0.01%
+7
New +$808
MMS icon
1343
Maximus
MMS
$3.14B
$914 ﹤0.01%
10
UPST icon
1344
Upstart Holdings
UPST
$2.58B
$914 ﹤0.01%
+18
New +$1.27K
ALGT icon
1345
Allegiant Air
ALGT
$2.64B
$912 ﹤0.01%
+15
New +$860
QRVO icon
1346
Qorvo
QRVO
$7.63B
$911 ﹤0.01%
10
OSK icon
1347
Oshkosh
OSK
$9.67B
$908 ﹤0.01%
7
MED icon
1348
Medifast
MED
$108M
$902 ﹤0.01%
+66
New +$922
RARE icon
1349
Ultragenyx Pharmaceutical
RARE
$2.65B
$902 ﹤0.01%
+30
New +$900
BLKB icon
1350
Blackbaud
BLKB
$1.5B
$900 ﹤0.01%
14
-857
-98% -$56.1K

Similar funds

TD Private Client Wealth's Q3 2025 Portfolio in Review

As of Q3 2025, TD Private Client Wealth held 1,573 positions worth $4.44B, up 9.1% from $4.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

TD Private Client Wealth deployed $154M of net new capital in Q3 2025, opening 168 new positions and adding to 590 existing holdings. Its largest new stake was UL Solutions: 23,723 shares worth $1.68M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $14.4M trimmed.

  • TD Private Client Wealth's largest Q3 2025 buy was UL Solutions: 23,723 shares worth $1.68M.
  • TD Private Client Wealth added most to Invesco S&P 500 Momentum ETF in Q3 2025, an estimated $28.4M increase.
  • TD Private Client Wealth's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $14.4M.
  • TD Private Client Wealth fully exited Hess in Q3 2025, selling an estimated $714K.
  • TD Private Client Wealth's ten largest holdings make up 38% of its $4.44B portfolio in Q3 2025.
  • TD Private Client Wealth opened 168 new positions and closed 38 in Q3 2025.
  • TD Private Client Wealth's portfolio value rose 9.1% quarter-over-quarter to $4.44B.

Based on TD Private Client Wealth's 13F filing for Q3 2025, filed 27 Oct 2025.